Studies have found that DEPDC1 is associated with cell cycle progression, and abnormal expression of DEPDC1 can be observed in numerous malignant tumors including bladder cancer, breast cancer, and hepatocellular cancer (HCC).11, 12, 13, 14, 15, 16, 17, 18, 19. This evidence concerns the gene DEPDC1 and urinary bladder carcinoma.